Previous Close | 91.87 |
Open | 93.74 |
Bid | 91.24 x 900 |
Ask | 96.09 x 1000 |
Day's Range | 93.65 - 95.43 |
52 Week Range | 35.49 - 113.06 |
Volume | 68,718 |
Avg. Volume | 123,910 |
Net Assets | 241.45M |
NAV | 92.04 |
PE Ratio (TTM) | N/A |
Yield | 0.00% |
YTD Daily Total Return | 6.82% |
Beta (5Y Monthly) | 1.95 |
Expense Ratio (net) | 0.95% |
Inception Date | 2010-04-06 |
Marc Lichtenfeld, an expert in biotech and income stocks, notes that a lot of Wall Street money moves into companies that issue positive Phase 2 clinical trial data.
Nasdaq Stock Exchange President Nelson Griggs joins Yahoo Finance’s Seana Smith to discuss market operations amid the coronavirus and the outlook on IPOs.